TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA

被引:89
作者
Chockalingam, Annapoorani
Brooks, James C. [2 ]
Cameron, Jody L.
Blum, Lisa K. [2 ]
Leifer, Cynthia A. [1 ]
机构
[1] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA
[2] Cornell Grad Sch, Field Immunol, Ithaca, NY USA
基金
美国国家卫生研究院;
关键词
brefeldin A; CpG DNA; endolysosome; Golgi; TLR9; trafficking; TOLL-LIKE RECEPTOR-9; NF-KAPPA-B; CUTTING EDGE; SELF-DNA; ACTIVATION; PROTEIN; CELLS; TOLL-LIKE-RECEPTOR-9; MACROPHAGES; RECOGNITION;
D O I
10.1038/icb.2008.101
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Toll-like receptor 9 (TLR9) promiscuously binds self-and microbial DNA, but only microbial DNA elicits an inflammatory response. How TLR9 discriminates between self-and foreign DNA is unclear, but inappropriate localization of TLR9 permits response to self-DNA, suggesting that TLR9 localization and trafficking are critical components. The molecular mechanisms controlling the movement of TLR9 may provide new insight into the recognition of DNA in normal and in pathological conditions such as autoimmune systemic lupus erythematosus. We have shown earlier that TLR9 is retained in the endoplasmic reticulum (ER) and it moves to endolysosomes to recognize CpG DNA. Other studies have suggested that TLR9 bypasses the Golgi complex to access endolysosomes. Here, we show that TLR9 translocates from ER to endolysosomes through the Golgi complex and that Golgi export is required for optimal TLR9 signaling. In all, 6-13% of TLR9 constitutively exits the ER, moves through the Golgi complex and resides in lysosomal-associated membrane protein-1-positive vesicles. TLR9 bound to CpG DNA had glycan modifications indicative of Golgi processing confirming that TLR9 travels through the Golgi complex to access CpG DNA in endolysosomes. Together, these data support a model where TLR9 uses traditional secretory pathways and does not bypass the Golgi complex.
引用
收藏
页码:209 / 217
页数:9
相关论文
共 39 条
[1]  
Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO
[2]  
2-U
[3]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[4]   Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis [J].
Asagiri, Masataka ;
Hirai, Toshitake ;
Kunigami, Toshihiro ;
Kamano, Shunya ;
Gober, Hans-Juergen ;
Okamoto, Kazuo ;
Nishikawa, Keizo ;
Latz, Eicke ;
Golenbock, Douglas T. ;
Aoki, Kazuhiro ;
Ohya, Keiichi ;
Imai, Yuuki ;
Morishita, Yasuyuki ;
Miyazono, Kohei ;
Kato, Shigeaki ;
Saftig, Paul ;
Takayanagi, Hiroshi .
SCIENCE, 2008, 319 (5863) :624-627
[5]   Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA [J].
Barton, GM ;
Kagan, JC ;
Medzhitov, R .
NATURE IMMUNOLOGY, 2006, 7 (01) :49-56
[6]   The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling [J].
Brinkmann, Melanie M. ;
Spooner, Eric ;
Hoebe, Kasper ;
Beutler, Bruce ;
Ploegh, Hidde L. ;
Kim, You-Me .
JOURNAL OF CELL BIOLOGY, 2007, 177 (02) :265-275
[7]   The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-Containing antigens [J].
Chaturvedi, Akanksha ;
Dorward, David ;
Pierce, Susan K. .
IMMUNITY, 2008, 28 (06) :799-809
[8]  
Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405
[9]   Cutting edge: Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression [J].
Gewirtz, AT ;
Navas, TA ;
Lyons, S ;
Godowski, PJ ;
Madara, JL .
JOURNAL OF IMMUNOLOGY, 2001, 167 (04) :1882-1885
[10]   Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation [J].
Guiducci, Cristiana ;
Ott, Gary ;
Chan, Jean H. ;
Damon, Emily ;
Calacsan, Carlo ;
Matray, Tracy ;
Lee, Kyung-Dall ;
Man, Robert L. Coff ;
Barrat, Franck J. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (08) :1999-2008